Immunoassay Reagent Frend
COVID-19 Total Ab SARS-CoV-2 Total
For FREND System 20 Tests
NanoEnTek FRCOD-020

Product Description

Immunoassay Reagent Frend
COVID-19 Total Ab SARS-CoV-2 Total
For FREND System 20 Tests
NanoEnTek FRCOD-020
Features
The FREND COVID-19 total Ab assay is only for use under the Food and Drug Administrations Emergency Use Authorization: https://www.fda.gov/medical-devices/emergency-situations-medical-devices/emergency-use-authorizations
Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C 263a, that meet requirements to perform moderate or high complexity tests
The FREND COVID-19 total Ab is a fluorescence immunoassay (FIA) using the FREND System intended for the qualitative detection of total antibody to SARS-CoV-2 in human dipotassium EDTA plasma
FREND COVID-19 total Ab is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection
At this time, it is unknown for how long antibodies persist following infection and if the presence of antibodies confers protective immunity; the FREND COVID-19 total Ab should not be used to diagnose acute SARSCoV-2 infection
Laboratories within the United States and its territories are required to report all results to the appropriate public health authorities
The sensitivity of FREND COVID-19 total Ab early after infection is unknown
Negative results do not preclude acute SARS-CoV-2 infection; if acute infection is suspected, direct testing for SARS-CoV2 is necessary
False positive results for FREND COVID-19 total Ab may occur due to cross-reactivity from preexisting antibodies or other possible causes
Due to the risk of false positive results, confirmation of positive results should be considered using second, different total antibody assay
Results can be obtained in less than 3 minutes with only 35 l of sample volume using the FREND System
Kit includes: 20 cartridges, 20 dilution tubes, 40 disposable pipette tips, code chip, and package insert
The following materials are NOT provided with the reagent but are required to perform COVID-19 total antibody analysis using the FREND COVID-19 total Ab on the FREND System: FREND System including calibrated pipette and QC Cartridge and QC Code chip manufactured by NanoEntek
Manufacturer # FRCOD-020
Brand Frend COVID-19 Total Ab
Manufacturer NanoEnTek USA Inc
Country of Origin Unknown
Application Immunoassay Reagent
For Use With For FREND System
Number of Tests 20 Tests
Sample Type Plasma Sample
Specialty Immunoassay
Test Category Respiratory
Test Format Cartridge
Test Method Fluorescene Immunoassay (FIA)
Test Name SARS-CoV-2 Total
Test Type Antibody Test
Time to Results 3 Minute Results
UNSPSC Code 41116126
Volume 35 L Sample Volume